PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: PAR Expanded Access IND Cleared by US FDA, page-12

  1. 300 Posts.
    lightbulb Created with Sketch. 38
    what are you smoking bud? do your research we are entering a Phase 3 clinical trial. No other company has got this far
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.